Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Genscript Corporation CLEC12A/MICL/CLL-1 His Cynom
Supplier: Genscript Corporation Z03962500
CLEC12A has recently been identified as an antigen expressed on leukemic stem cells and leukemic blasts Given the fact that this expression profile seems stable throughout diagnosis treatment and relapse on leukemic blasts and leukemic stem cells CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?